International HIFU

Sonablate Corp, formerly known as SonaCare Medical and US HIFU, is a leading medical device company specializing in minimally invasive High-Intensity Focused Ultrasound (HIFU) technologies. The company's flagship product, the Sonablate system, is an image-guided surgical ablation tool used primarily for the treatment of prostate cancer and benign prostatic hyperplasia (BPH). Sonablate received FDA clearance for prostate tissue ablation in 2015 and is currently utilized in over 50 countries worldwide. The company is also expanding its technology into new therapeutic areas, including the treatment of chronic venous insufficiency through its HIFIVE clinical trial. Headquartered in Charlotte, North Carolina, Sonablate Corp operates through subsidiaries such as Focus Surgery and UKHIFU, maintaining a strong global presence in the field of therapeutic ultrasound.